| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051847A1 Processes for preparing calanolide a and intermediates thereof |
| 07/04/2002 | WO2002051844A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 07/04/2002 | WO2002051843A1 Novel purine derivatives, preparation method and use as medicines |
| 07/04/2002 | WO2002051842A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051840A1 Method for producing the anticholinergic agent tiotropium bromide |
| 07/04/2002 | WO2002051839A1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt |
| 07/04/2002 | WO2002051838A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/04/2002 | WO2002051837A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051834A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051833A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders |
| 07/04/2002 | WO2002051832A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | WO2002051828A2 Novel c-glycoside derivatives and use thereof |
| 07/04/2002 | WO2002051824A1 Amidinophenylalanine derivatives as thrombin inhibitors |
| 07/04/2002 | WO2002051821A1 Therapeutic compounds |
| 07/04/2002 | WO2002051819A2 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051809A1 Piperidine mch antagonists and their use in the treatment of obesity |
| 07/04/2002 | WO2002051808A2 Muscarinic antagonists |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051806A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | WO2002051805A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | WO2002051804A1 Crystalline forms of atorvastatin |
| 07/04/2002 | WO2002051535A2 Preparation of microparticles having improved flowability |
| 07/04/2002 | WO2002051502A1 Combined inhibition of phosphodiesterase-4 (pde-4) and phosphodiesterase-3 (pde-3) as a therapy for th1-mediated autoimmune diseases |
| 07/04/2002 | WO2002051452A1 Process to improve stability of a pharmaceutical composition |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051441A1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 07/04/2002 | WO2002051440A1 Combination drugs |
| 07/04/2002 | WO2002051439A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051437A1 Induction of tolerance |
| 07/04/2002 | WO2002051431A1 Therapeutic and/or preventive agents for diseases due to retinal ischemia |
| 07/04/2002 | WO2002051428A1 Sympathetic-activating perfume composition |
| 07/04/2002 | WO2002051427A1 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament |
| 07/04/2002 | WO2002051426A2 Compositions and methods for treating sexual dysfunction, enhancing sexual function, increasing testosterone levels, and improving muscle strength and mass |
| 07/04/2002 | WO2002051425A1 Remedies for hepatitis c |
| 07/04/2002 | WO2002051424A1 Drugs against articular failure |
| 07/04/2002 | WO2002051423A1 Angiogenesis inhibitors |
| 07/04/2002 | WO2002051422A1 Preventives/ermedies for inflammatory airway diseases |
| 07/04/2002 | WO2002051421A2 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
| 07/04/2002 | WO2002051420A2 Methods and formulations for the treatment of female sexual dysfunction |
| 07/04/2002 | WO2002051419A2 A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv |
| 07/04/2002 | WO2002051418A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 07/04/2002 | WO2002051417A1 Thermofomable solid pharmaceutical composition for controlled release of trimetazidine |
| 07/04/2002 | WO2002051416A1 Drugs for improving ability of daily life behaviors in alzheimer's disease |
| 07/04/2002 | WO2002051415A2 Use of sequestrants for treating prion diseases |
| 07/04/2002 | WO2002051414A1 Medicinal compositions for oral use |
| 07/04/2002 | WO2002051413A2 Macrocyclic anti-viral compounds |
| 07/04/2002 | WO2002051412A1 Medicinal compositions containing aspirin |
| 07/04/2002 | WO2002051411A1 Famotidine injections |
| 07/04/2002 | WO2002051410A2 Phenylthiazole and thiazoline derivatives and their use as antiparasitics |
| 07/04/2002 | WO2002051408A1 Azole compounds as anti-fungals agents |
| 07/04/2002 | WO2002051407A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | WO2002051406A1 Methods for inducing apoptosis and inhibiting proliferation in cancer cells |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002051403A1 Compositions of stable t3 and methods of use thereof |
| 07/04/2002 | WO2002051402A1 Controlled release formulation of divalproex sodium |
| 07/04/2002 | WO2002051401A2 Controlled release formulations of divalproex sodium |
| 07/04/2002 | WO2002051400A2 Solid dosage forms of divalproex sodium |
| 07/04/2002 | WO2002051399A2 Divalproex sodium dosage forms and a process for their production |
| 07/04/2002 | WO2002051398A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof |
| 07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 07/04/2002 | WO2002051395A1 Treatment of neurodegenerative diseases |
| 07/04/2002 | WO2002051394A1 Dermatological compositions and methods |
| 07/04/2002 | WO2002051393A2 Process to increase the concentration of meiosis-activating sterols (mas) in the cholesterol synthesis and the use of potent inhibitors in the process |
| 07/04/2002 | WO2002051389A2 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | WO2002051388A2 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/04/2002 | WO2002051387A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 07/04/2002 | WO2002051385A1 Solid dispersions of nitrate active principles |
| 07/04/2002 | WO2002051383A2 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
| 07/04/2002 | WO2002051356A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 07/04/2002 | WO2002051264A2 Nutritional composition with health promoting action containing oligo-saccharides |
| 07/04/2002 | WO2002051260A1 Coated chewing gum products containing an antigas agent |
| 07/04/2002 | WO2002051259A1 Coated chewing gum products containing various antacids |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002051232A2 Novel benzazepines and related heterocyclic derivatives |
| 07/04/2002 | WO2002038543A3 3-substituted oxindole beta 3 agonists |
| 07/04/2002 | WO2002036556A3 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 07/04/2002 | WO2002034710A3 Novel intermediates for use in retinoid synthesis |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002032373A3 Estrogen receptor modulators |
| 07/04/2002 | WO2002028361A3 Compositions for cleansing skin and treating acne |
| 07/04/2002 | WO2002028347A3 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002026324A3 Tocol-based compositions containing amiodarone |
| 07/04/2002 | WO2002026233B1 Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 07/04/2002 | WO2002022110A3 Contraception process and administration form for the same |
| 07/04/2002 | WO2002020486A3 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 07/04/2002 | WO2002017917A8 Manzamines for treatment of drug resistant infection |
| 07/04/2002 | WO2002017898A3 Compositions and methods for inducing vasorelaxation |
| 07/04/2002 | WO2002015904B1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 07/04/2002 | WO2002014317A3 Substituted pyrazoles |
| 07/04/2002 | WO2002009684A8 Erbb-2 selective small molecule kinase inhibitors |
| 07/04/2002 | WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 07/04/2002 | WO2002003991A3 Use of substituted indole compounds for increasing nitric oxide synthase activity |
| 07/04/2002 | WO2002002076A3 Methods for treating inflammation-mediated conditions of the eye |